Suppr超能文献

增强的去甲肾上腺素能活动通过差异招募 α1-和 β-肾上腺素能受体来增强恐惧记忆的巩固和再巩固。

Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors.

机构信息

Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Santa Catarina, 88049-900, Brazil.

出版信息

Learn Mem. 2013 Mar 19;20(4):210-9. doi: 10.1101/lm.030007.112.

Abstract

Consolidation and reconsolidation are phases of memory stabilization that diverge slightly. Noradrenaline is known to influence both processes, but the relative contribution of α1- and β-adrenoceptors is unclear. The present study sought to investigate this matter by comparing their recruitment to consolidate and/or reconsolidate a contextual fear memory trace under enhanced noradrenergic activity induced by yohimbine. We report that this α2-adrenoceptor antagonist was able to potentiate fear memory trace consolidation or reconsolidation when administered immediately after acquisition or retrieval, respectively, resulting in increased freezing expression. In either case, generalization of this response to an unpaired context was also seen when it achieved a ceiling level in the paired context. These effects endured for over 7 d and relied on action at central rather than peripheral sites, but were prevented when a memory trace was not acquired, when memory reactivation was omitted, or when administration of yohimbine was delayed until 6 h after acquiring or retrieving the memory trace. The β-adrenoceptor antagonist propranolol was able to prevent the above-mentioned effects of yohimbine, while pretreatment with the α1-adrenoceptor antagonist prazosin blocked only its facilitating effects on memory reconsolidation. These results highlight a differential participation of α1- and β-adrenoceptors in fear memory processing. Moreover, it was shown that the α2-adrenoceptor agonist clonidine, as opposed to yohimbine, mitigates fear expression by weakening memory consolidation or reconsolidation.

摘要

巩固和再巩固是记忆稳定的两个阶段,略有不同。去甲肾上腺素被认为会影响这两个过程,但α1-和β-肾上腺素受体的相对贡献尚不清楚。本研究通过比较它们在育亨宾诱导的去甲肾上腺素能活性增强下,对巩固和/或再巩固情境恐惧记忆痕迹的招募情况,试图解决这个问题。我们报告说,这种α2-肾上腺素受体拮抗剂在获得后或检索后立即给药时,分别能够增强恐惧记忆痕迹的巩固或再巩固,导致冻结表达增加。在这两种情况下,当这种反应在配对环境中达到上限时,也会对未配对的环境产生泛化。这些效应持续超过 7 天,依赖于中枢而不是外周部位的作用,但当记忆痕迹未被获得、记忆再激活被省略或育亨宾给药延迟到获得或检索记忆痕迹后 6 小时时,这些效应就会被阻止。β-肾上腺素受体拮抗剂普萘洛尔能够阻止育亨宾的上述作用,而α1-肾上腺素受体拮抗剂哌唑嗪的预处理仅能阻止其对记忆再巩固的促进作用。这些结果突出了α1-和β-肾上腺素受体在恐惧记忆处理中的差异参与。此外,还表明与育亨宾相反,α2-肾上腺素受体激动剂可乐定通过削弱记忆的巩固或再巩固来减轻恐惧表达。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验